Targeted gene modifications in drug discovery and development

Current Opinion in Pharmacology

Volumn 9, Issue 5, 2009, Pages 657-663

  Cabaniols, Jean Pierre ^a   Mathis, Luc ^a   Delenda, Christophe ^a  

^a Arvid Wallgrens Backe 20   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CARRIER PROTEIN; CELL NUCLEUS RECEPTOR; CRE RECOMBINASE; G PROTEIN COUPLED RECEPTOR; ION CHANNEL; LENTIVIRUS VECTOR; LIPOSOME; NEW DRUG; PLASMID DNA;

ADENOVIRUS; AMPLICON; BACULOVIRUS; CELL ASSAY; CELL DIFFERENTIATION; CELL FUNCTION; CELL LINE; CELL TYPE; DNA MODIFICATION; DRUG RESEARCH; DRUG SCREENING; ELECTROPORATION; EXPRESSION VECTOR; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE SILENCING; GENE TARGETING; GENETIC ENGINEERING; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; HUMAN; LENTIVIRINAE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; SEMLIKI FOREST ALPHAVIRUS; STEM CELL; TECHNOLOGY; TRANSGENE;

ANIMALS; BIOLOGICAL ASSAY; CELL LINE; DRUG DISCOVERY; GENE EXPRESSION REGULATION; GENE TRANSFER TECHNIQUES; HUMANS; RECOMBINANT PROTEINS; RECOMBINASES; RECOMBINATION, GENETIC;

EID: 70349431229     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2009.05.001     Document Type: Review

References (65)

1. Bianchi B.R., Moreland R.B., Faltynek C.R., and Chen J. Application of large-scale transiently transfected cells to functional assays of ion channels: different targets and assay formats. Assay Drug Dev Technol 5 (2007) 417-424
2. Feng X., Castracane J., Tokranova N., Gracias A., Lnenicka G., and Szaro B.G. A living cell-based biosensor utilizing G-protein coupled receptors: principles and detection methods. Biosens Bioelectron 22 (2007) 3230-3237
3. Viswanath G., Halder S., Divya G., Majumder C.B., and Roy P. Detection of potential (anti)progestagenic endocrine disruptors using a recombinant human progesterone receptor binding and transactivation assay. Mol Cell Endocrinol 295 (2008) 1-9
4. Chen N., and Reith M.E. Substrates and inhibitors display different sensitivity to expression level of the dopamine transporter in heterologously expressing cells. J Neurochem 101 (2007) 377-388
5. Palmer E.L., Miller A.D., and Freeman T.C. Identification and characterisation of human apoptosis inducing proteins using cell-based transfection microarrays and expression analysis. BMC Genomic 7 (2006) 145
6. Majerová-Uhlíková T., Dantuma N.P., Lindsten K., Masucci M.G., and Konvalinka J. Non-infectious fluorimetric assay for phenotyping of drug-resistant HIV proteinase mutants. J Clin Virol 36 (2006) 50-59
7. Sorscher E.J., Harris J., Alexander M., Rottgers A., Hardy K., Ponnazhagan S., Collawn J.F., McClintock J., Amsler C.D., Webster A., et al. Activators of viral gene expression in polarized epithelial monolayers identified by rapid-throughput drug screening. Gene Ther 13 (2006) 781-788
8. Pfohl J.L., Worley III J.F., Condreay J.P., An G., Apolito C.J., Kost T.A., and Truax J.F. Titration of KATP channel expression in mammalian cells utilizing recombinant baculovirus transduction. Receptors Channels 8 (2002) 99-111
9. Ames R., Fornwald J., Nuthulaganti P., Trill J., Foley J., Buckley P., Kost T., Wu Z., and Romanos M. BacMam recombinant baculoviruses in G protein-coupled receptor drug discovery. Receptors Channels 10 (2004) 99-107
10. Boudjelal M., Mason S.J., Katso R.M., Fleming J.M., Parham J.H., Condreay J.P., Merrihew R.V., and Cairns W.J. The application of BacMam technology in nuclear receptor drug discovery. Biotechnol Annu Rev 11 (2005) 101-125
11. Hassan N.J., Pountney D.J., Ellis C., and Mossakowska D.E. BacMam recombinant baculovirus in transporter expression: a study of BCRP and OATP1B1. Protein Expr Purif 47 (2006) 591-598
12. Jenkinson S., McCoy D.C., Kerner S.A., Ferris R.G., Lawrence W.K., Clay W.C., Condreay J.P., and Smith C.D. Development of a novel high-throughput surrogate assay to measure HIV envelope/CCR5/CD4-mediated viral/cell fusion using BacMam baculovirus technology. J Biomol Screen 8 (2003) 463-470
13. Jardin B.A., Zhao Y., Selvaraj M., Montes J., Tran R., Prakash S., and Elias C.B. Expression of SEAP (secreted alkaline phosphatase) by baculovirus mediated transduction of HEK 293 cells in a hollow fiber bioreactor system. J Biotechnol 135 (2008) 272-280
14. Merrihew R.V., Clay W.C., Condreay J.P., Witherspoon S.M., Dallas W.S., and Kost T.A. Chromosomal integration of transduced recombinant baculovirus DNA in mammalian cells. J Virol 75 (2001) 903-909
15. Michiels F., van Es H., van Rompaey L., Merchiers P., Francken B., Pittois K., van der Schueren J., Brys R., Vandersmissen J., Beirinckx F., et al. Arrayed adenoviral expression libraries for functional screening. Nat Biotechnol 20 (2002) 1154-1157. Authors have settled an individually arrayed, replication-defective adenoviral library harboring human cDNAs. The arrayed format has allowed the identification of regulators of osteogenesis, metastasis, and angiogenesis in a variety of different cell types including primary cells.
16. Kodama S., Moore R., Yamamoto Y., and Negishi M. Human nuclear pregnane X receptor cross-talk with CREB to repress cAMP activation of the glucose-6-phosphatase gene. Biochem J 407 (2007) 373-381
17. Pérez-Torras S., García-Manteiga J., Mercadé E., Casado F.J., Carbó N., Pastor-Anglada M., and Mazo A. Adenoviral-mediated overexpression of human equilibrative nucleoside transporter 1 (hENT1) enhances gemcitabine response in human pancreatic cancer. Biochem Pharmacol 76 (2008) 322-329
18. Forte A., Napolitano M.A., Cipollaro M., Giordano A., Cascino A., and Galderisi U. An effective method for adenoviral-mediated delivery of small interfering RNA into mesenchymal stem cells. J Cell Biochem 100 (2007) 293-302
19. Liu J., Lewin A.S., Tuli S.S., Ghivizzani S.C., Schultz G.S., and Bloom D.C. Reduction in severity of a herpes simplex virus type 1 murine infection by treatment with a ribozyme targeting the UL20 gene RNA. J Virol 82 (2008) 7467-7474
20. Wilson P.G., Cherry J.J., Schwamberger S., Adams A.M., Zhou J., Shin S., and Stice S.L. An SMA project report: neural cell-based assays derived from human embryonic stem cells. Stem Cells Dev 16 (2007) 1027-1041
21. Craig A.M. Transfecting cultured neurons. In: Banker G., and Goslin K. (Eds). Culturing Nerve Cells (2008), MIT Press, Boston, MA 79-111
22. Hagalili Y., Bachnoff N., and Atlas D. The voltage-gated Ca(2+) channel is the Ca(2+) sensor protein of secretion. Biochemistry 47 (2008) 13822-13830
23. Lundstrom K. Semliki Forest virus vectors for rapid and high-level expression of integral membrane proteins. Biochim Biophys Acta 1610 (2003) 90-96
24. Blasey H.D., Hovius R., Vogel H., and Bernard A.R. Transient-expression technologies, their application and scale-up: 5-HT3 serotonin receptor case study. Biochem Soc Trans 27 (1999) 956-960
25. Raunser S., Haase W., Bostina M., Parcej D.N., and Kühlbrandt W. High-yield expression, reconstitution and structure of the recombinant, fully functional glutamate transporter GLT-1 from Rattus norvegicus. J Mol Biol 351 (2005) 598-613
26. Garcia S., Billecocq A., Crance J.M., Prins M., Garin D., and Bouloy M. Viral suppressors of RNA interference impair RNA silencing induced by a Semliki Forest virus replicon in tick cells. J Gen Virol 87 (2006) 1985-1989
27. Gauczynski S., Nikles D., El-Gogo S., Papy-Garcia D., Rey C., Alban S., Barritault D., Lasmezas C.I., and Weiss S. The 37-kDa/67-kDa laminin receptor acts as a receptor for infectious prions and is inhibited by polysulfated glycanes. J Infect Dis 194 (2006) 702-709
28. Song Y., Buelow B., Perraud A.L., and Scharenberg A.M. Development and validation of a cell-based high-throughput screening assay for TRPM2 channel modulators. J Biomol Screen 13 (2008) 54-61
29. Nawoschik S.P., Olsen M., Smith D.L., and Khawaja X. Stable expression of adenylyl cyclase 2 leads to the functional rescue of human 5-HT6 receptor in a CHODUKX cell line. J Pharmacol Toxicol Method 55 (2007) 323-331
30. Chen J., Ahn K.C., Gee N.A., Gee S.J., Hammock B.D., and Lasley B.L. Antiandrogenic properties of parabens and other phenolic containing small molecules in personal care products. Toxicol Appl Pharmacol 221 (2007) 278-284
31. Gao J., Xu Y., Yang Y., Yang Y., Zheng Z., Jiang W., Hong B., Yan X., and Si S. Identification of upregulators of human ATP-binding cassette transporter A1 via high-throughput screening of a synthetic and natural compound library. J Biomol Screen 13 (2008) 648-656
32. Cahill A.L., Moore J.M., Sabar F.I., and Harkins A.B. Variability in RNA interference in neuroendocrine PC12 cell lines stably transfected with an shRNA plasmid. J Neurosci Methods 166 (2007) 236-240
33. Lembo D., Donalisio M., De Andrea M., Cornaglia M., Scutera S., Musso T., and Landolfo S. A cell-based high-throughput assay for screening inhibitors of human papillomavirus-16 long control region activity. FASEB J 20 (2006) 148-150
34. Yang X.J., Zhou Y.F., Li H.X., Han L.H., and Jiang W.P. Mesenchymal stem cells as a gene delivery system to create biological pacemaker cells in vitro. J Int Med Res 36 (2009) 1049-1055
35. Kalari S., Zhao Y., Spannhake E.W., Berdyshev E.V., and Natarajan V. Role of acylglycerol kinase in LPA-induced IL-8 secretion and transactivation of epidermal growth factor-receptor in human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol 296 (2009) L328-L336
36. Sharma S., and Lichtenstein A. Dexamethasone-induced apoptotic mechanisms in myeloma cells investigated by analysis of mutant glucocorticoid receptors. Blood 112 (2008) 1338-1345
37. Todesco L., Bur D., Brooks H., Török M., Landmann L., Stieger B., and Krähenbühl S. Pharmacological manipulation of L-carnitine transport into L6 cells with stable overexpression of human OCTN2. Cell Mol Life Sci 65 (2008) 1596-1608
38. Hwang J.I., Choi S., Fraser I.D., Chang M.S., and Simon M.I. Silencing the expression of multiple Gbeta-subunits eliminates signaling mediated by all four families of G proteins. Proc Natl Acad Sci USA 102 (2005) 9493-9498
39. Paddison P.J., Silva J.M., Conklin D.S., Schlabach M., Li M., Aruleba S., Balija V., O'Shaughnessy A., Gnoj L., Scobie K., et al. A resource for large-scale RNA-interference-based screens in mammals. Nature 428 (2004) 427-431
40. Zanella F., Rosado A., Garcia B., Carnero A., and Link W. Using multiplexed regulation of luciferase activity and GFP translocation to screen for FOXO modulators. BMC Cell Biol 10 (2009) 14
41. Beard B.C., Dickerson D., Beebe K., Gooch C., Fletcher J., Okbinoglu T., Miller D.G., Jacobs M.A., Kaul R., Kiem H.P., et al. Comparison of HIV-derived lentiviral and MLV-based gammaretroviral vector integration sites in primate repopulating cells. Mol Ther 15 (2007) 1356-1365
42. Sorrell D.A., and Kolb A.F. Targeted modification of mammalian genomes. Biotechnol Adv 23 (2005) 431-469
43. Sangiorgi E., Shuhua Z., and Capecchi M.R. In vivo evaluation of PhiC31 recombinase activity using a self-excision cassette. Nucleic Acids Res 36 (2008) 134. This paper proposes the PhiC31 phage integrase as an alternative to Phage P1 Cre recombinase for the manipulation of eukaryotic genome.
44. Maucksch C., Aneja M.K., Hennen E., Bohla A., Hoffmann F., Elfinger M., Rosenecker J., and Rudolph C. Cell type differences in activity of the Streptomyces bacteriophage phiC31 integrase. Nucleic Acids Res 36 (2008) 5462-5471
45. Olivares E.C., Hollis R.P., and Calos M.P. Phage R4 integrase mediates site-specific integration in human cells. Gene 278 (2001) 167-176
46. Lam A.D., Chikina M.D., McNulty M.M., Glaaser I.W., and Hanck D.A. Role of Domain IV/S4 outermost arginines in gating of T-type calcium channels. Pflugers Arch 451 (2005) 349-361
47. Roy S., Rached M., and Gallo-Payet N. Differential regulation of the human adrenocorticotropin receptor [melanocortin-2 receptor (MC2R)] by human MC2R accessory protein isoforms alpha and beta in isogenic human embryonic kidney 293 cells. Mol Endocrinol 21 (2007) 1656-1669
48. Nair R.R., Avila H., Ma X., Wang Z., Lennartz M., Darnay B.G., Boyd D.D., and Yan C. A novel high-throughput screening system identifies a small molecule repressive for matrix metalloproteinase-9 expression. Mol Pharmacol 73 (2008) 919-929. The authors describe a novel promoter-reporter construct inserted through the Flp-In system allowing the rapid screen of more than 8000 compounds.
49. Castaneda F., and Kinne R.K. A 96-well automated method to study inhibitors of human sodium-dependent D-glucose transport. Mol Cell Biochem 280 (2005) 91-98
50. Haynes K.A., Caudy A.A., Collins L., and Elgin S.C. Element 1360 and RNAi components contribute to HP1-dependent silencing of a pericentric reporter. Curr Biol 16 (2006) 2222-2227
51. Zhu H.J., Appel D.I., Johnson J.A., Chavin K.D., and Markowitz J.S. Role of carboxylesterase 1 and impact of natural genetic variants on the hydrolysis of trandolapril. Biochem Pharmacol 77 (2009) 1266-1272
52. Kapitskaya M., Cunningham M.E., Lacson R., Kornienko O., Bednar B., and Petrukhin K. Development of the high throughput screening assay for identification of agonists of an orphan nuclear receptor. Assay Drug Dev Technol 4 (2006) 253-262
53. Liu W., Xiong Y., and Gossen M. Stability and homogeneity of transgene expression in isogenic cells. J Mol Med 84 (2006) 57-64
54. Qureshi S.A., Sanders P., Zeh K., Whitney M., Pollok B., Desai R., Whitney P., Robers M., and Hayes S.A. A one-arm homologous recombination approach for developing nuclear receptor assays in somatic cells. Assay Drug Dev Technol 1 (2003) 767-776
55. Rouet P., Smih F., and Jasin M. Expression of a site-specific endonuclease stimulates homologous recombination in mammalian cells. Proc Natl Acad Sci USA 91 (1994) 6064-6068
56. Choulika A., Perrin A., Dujon B., and Nicolas J.F. Induction of homologous recombination in mammalian chromosomes by using the I-SceI system of Saccharomyces cerevisiae. Mol Cell Biol 15 (1995) 1968-1973
57. Cabaniols J.P., and Pâques F. Robust cell line development using meganucleases. Methods Mol Biol 435 (2008) 31-45
58. Cabaniols et al., manuscript in preparation.
59. Bibikova M., Carroll D., Segal D.J., Trautman J.K., Smith J., Kim Y.G., and Chandrasegaran S. Stimulation of homologous recombination through targeted cleavage by chimeric nucleases. Mol Cell Biol 21 (2001) 289-297
60. Miller J.C., Holmes M.C., Wang J., Guschin D.Y., Lee Y.L., Rupniewski I., Beausejour C.M., Waite A.J., Wang N.S., et al. An improved zinc-finger nuclease architecture for highly specific genome editing. Nat Biotechnol 25 (2007) 778-785
61. Santiago Y., Chan E., Liu P.Q., Orlando S., Zhang L., Urnov F.D., Holmes M.C., Guschin D., Waite A., Miller J.C., et al. Targeted gene knockout in mammalian cells using engineered zinc-finger nucleases. Proc. Natl. Acad. Sci. 105 (2008) 5809-5814. In this paper, the authors used zinc-finger nuclease for gene disruption (DHFR) in mammal cells. These data illustrate the potency of targeted genome modification for rapid generation of cell lines.
62. Redondo P., Prieto J., Munoz I.G., Alibés A., Stricher F., Serrano L., Cabaniols J.P., Daboussi F., Arnould S., Perez C., et al. Molecular basis of xeroderma pigmentosum group C DNA recognition by engineered meganucleases. Nature 456 (2008) 107-113. This work demonstrates that engineered meganucleases, designed to cleave the human XPC gene, induced high levels of specific gene targeting in mammal cells. It proves that these endonucleases are powerful tools for genome engineering and gene therapy.
63. Moehle E.A., Rock J.M., Lee Y.L., Jouvenot Y., DeKelver R.C., Gregory P.D., Urnov F.D., and Holmes M.C. Targeted gene addition into a specified location in the human genome using designed zinc finger nucleases. Proc Natl Acad Sci USA 104 (2007) 3055-3060
64. Arnould S., Chames P., Perez C., Lacroix E., Duclert A., Epinat J.C., Stricher F., Petit A.S., Patin A., Guillier S., et al. Engineering of large numbers of highly specific homing endonucleases that induce recombination on novel DNA targets. J Mol Biol 355 (2006) 443-458
65. Smith J., Grizot S., Arnould S., Duclert A., Epinat J.C., Chames P., Prieto J., Redondo P., Blanco F.J., Bravo J., et al. A combinatorial approach to create artificial homing endonucleases cleaving chosen sequences. Nucleic Acids Res 34 (2006) 149